ALX ONCOLOGY HLDGS INC shareholders Q3 2023

ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 78 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

ALX ONCOLOGY HLDGS INC shareholders Q3 2023
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$46,559,64013.20%
Vivo Capital, LLC 4,220,048$20,256,2302.22%
Logos Global Management LP 1,000,000$4,800,0000.64%
Orbimed Advisors 2,871,000$13,780,8000.29%
Redmile Group, LLC 1,283,289$6,159,7870.29%
BRAIDWELL LP 1,249,900$5,999,5200.19%
Cormorant Asset Management, LP 612,079$2,937,9790.17%
Nan Fung Group Holdings Ltd 41,950$201,3600.16%
Forefront Analytics, LLC 13,769$66,0920.04%
CORNERCAP INVESTMENT COUNSEL INC 35,071$168,3410.03%
Virtus ETF Advisers LLC 10,727$51,4900.03%
Financial Advisory Group 31,417$150,8020.03%
BOURGEON CAPITAL MANAGEMENT LLC 19,570$93,9360.02%
XTX Topco Ltd 10,740$51,5520.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 48,500$232,8000.01%
MARTINGALE ASSET MANAGEMENT L P 44,609$214,1240.01%
Bradley & Co. Private Wealth Management, LLC 1,000$4,8000.01%
FEDERATED HERMES, INC. 251,360$1,206,5280.00%
LOS ANGELES CAPITAL MANAGEMENT LLC 146,677$704,0500.00%
PRELUDE CAPITAL MANAGEMENT, LLC 10,900$52,3200.00%
External links

This page lists ALX ONCOLOGY HLDGS INC's shareholders in Q3 2023. To view ALX ONCOLOGY HLDGS INC's shareholder history, click here.